ArticleMolecular genetics and genomics : MGG2026
HIPK3 silencing promotes M2 macrophage polarization through NF-κB signaling pathway to enhance oral cancer progression.
Article in Molecular genetics and genomics : MGG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The tumor microenvironment (TME) is crucial for the progression of oral cancer. A key feature of the TME is the dynamic plasticity of tumor-associated macrophages (TAMs), which can polarize into either pro-inflammatory M1 or anti-inflammatory M2 phenotypes. This study aimed to investigate the role of homeodomain-interacting protein kinase 3 (HIPK3) in regulating macrophage polarization and its consequent impact on the behavior of oral squamous cell carcinoma (OSCC) cell line CAL-27. Following transfection of M0 with si-HIPK3 to downregulate HIPK3 expression, we assessed macrophage polarization markers via ELISA. Protein levels of iNOS and Arg1 were further evaluated by Western blot. We subsequently examined the effect of HIPK3-silenced macrophage polarization on the behavior of OSCC cells using functional assays. Finally, the molecular mechanism through which HIPK3 silencing regulates macrophage polarization was investigated. HIPK3 knockdown induced a significant shift from anti-tumor M1 polarization, characterized by decreased iNOS and TNF-α expression, to a tumor-promoting M2 phenotype, as evidenced by elevated levels of Arg1 and CD163. Functional assays further demonstrated that HIPK3 silencing markedly enhanced the proliferation, migration, and invasion capabilities of CAL-27 cells. Mechanistically, HIPK3 likely facilitates macrophage M2 polarization by inhibiting the NF-κB signaling pathway. In conclusion, inhibition of HIPK3 promotes M2 macrophage polarization, which in turn enhances the proliferation and migration of OSCC cells, ultimately contributing to pro-tumorigenic effects.
Indexed as
Identifiers
42371219What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.